A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients With Early Stage Cancer of the Endometrium
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Levonorgestrel (Primary) ; Metformin
- Indications Endometrial cancer
- Focus Therapeutic Use
- Acronyms feMMe
- 13 Oct 2015 Planned End Date changed from 1 Sep 2015 to 1 Jun 2017 as reported by the ClinicalTrials.gov record.
- 13 Oct 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jun 2017 as reported by the ClinicalTrials.gov record.
- 03 Jun 2013 Planned number of patients changed from 111 to 165 as reported by ClinicalTrials.gov record.